Seelos Therapeutics (NASDAQ: SEEL)
$0.29
(0.7%)
$0.00
Price as of April 26, 2024, 9:33 a.m. ET
Seelos Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Seelos Therapeutics Company Info
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.
News & Analysis
Featured Article
Why Seelos Therapeutics Stock Is Jumping Today
The company has been included in the first U.S. psychedelics-focused ETF.
Keith Speights | Jun 1, 2021
Featured Article
Why Seelos Therapeutics Dived by 24% Today
Good news from a clinical study was overshadowed by a recommendation downgrade from an analyst.
Eric Volkman | May 17, 2021
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.